Evidence map›Paper›PMID 32991049›Full record

ArticleCNS neuroscience & therapeutics2021

Variants of WNT7A and GPR124 are associated with hemorrhagic transformation following intravenous thrombolysis in ischemic stroke.

Song Ta, Xianfang Rong, Zhen-Ni Guo, Hang Jin, Peng Zhang, Fenge Li, Zhihuan Li, Lilong Lin, Chenqing Zheng, Qingquan Gu and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in CNS neuroscience & therapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05585255 (Clinical Significance, Mechanism of Action, and New Targeted Drug Research of DKK2 Protein in Cerebral Ischemia-reperfusion Injury), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05585255 unknown statusnot on this mapstarted 2022, after this paper: background citation

Clinical Significance, Mechanism of Action, and New Targeted Drug Research of DKK2 Protein in Cerebral Ischemia-reperfusion Injury

Typeobservational_patient_registrySponsorNanfang Hospital, Southern Medical UniversityRan2022 to 2024Enrolled108ConditionsIschemic Stroke, Acute, Ischemia-reperfusion Injury, Cerebral EdemaArmsenzyme-linked immunosorbent assay(ELISA)
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Efficacy and safety of spot heating and ultrasound irradiation on in vitro and in vivo thrombolysis models.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Song TaDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Xianfang RongShenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.
Zhen-Ni GuoDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Hang JinDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Peng ZhangDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Fenge LiDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Zhihuan LiDongguan Enlife Stem Cell Biotechnology Institute, Dongguan, China.
Lilong LinDongguan Enlife Stem Cell Biotechnology Institute, Dongguan, China.
Chenqing ZhengShenzhen RealOmics Biotech Co., Ltd., Shenzhen, China.
Qingquan GuShenzhen RealOmics Biotech Co., Ltd., Shenzhen, China.
Yuan ZhangThe Central Laboratory, Shenzhen Second People's Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen University School of Medicine, Shenzhen, China.
Wenlan LiuThe Central Laboratory, Shenzhen Second People's Hospital, Shenzhen University 1st Affiliated Hospital, Shenzhen University School of Medicine, Shenzhen, China.
Yi YangDepartment of Neurology, The First Hospital of Jilin University, Changchun, China.
Junlei ChangShenzhen Key Laboratory of Biomimetic Materials and Cellular Immunomodulation, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China.ORCID 0000-0002-0319-9022
Jilin University · CNChinese Academy of Sciences · CNDongguan People’s Hospital · CNLifetech Scientific (China) · CNShenzhen Second People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThe canonical Wnt signaling pathway plays an essential role in blood-brain barrier integrity and intracerebral hemorrhage in preclinical stroke models. Here, we sought to explore the association between canonical Wnt signaling and hemorrhagic transformation (HT) following intravenous thrombolysis (IVT) in acute ischemic stroke (AIS) patients as well as to determine the underlying cellular mechanisms.

methods355 consecutive AIS patients receiving IVT were included. Blood samples were collected on admission, and HT was detected at 24 hours after IVT. 117 single-nucleotide polymorphisms (SNPs) of 28 Wnt signaling genes and exon sequences of 4 core cerebrovascular Wnt signaling components (GPR124, RECK, FZD4, and CTNNB1) were determined using a customized sequencing chip. The impact of identified genetic variants was further studied in HEK 293T cells using cellular and biochemical assays.

resultsDuring the study period, 80 patients experienced HT with 27 parenchymal hematoma (PH). Compared to the non-PH patients, WNT7A SNPs (rs2163910, P = .001, OR 2.727; rs1124480, P = .002, OR 2.404) and GPR124 SNPs (rs61738775, P = .012, OR 4.883; rs146016051, P < .001, OR 7.607; rs75336000, P = .044, OR 2.503) were selectively enriched in the PH patients. Interestingly, a missense variant of GPR124 (rs75336000, c.3587G>A) identified in the PH patients resulted in a single amino acid alteration (p.Cys1196Tyr) in the intracellular domain of GPR124. This variant substantially reduced the activity of WNT7B-induced canonical Wnt signaling by decreasing the ability of GPR124 to recruit cytoplasmic DVL1 to the cellular membrane.

conclusionVariants of WNT7A and GPR124 are associated with increased risk of PH in patients with AIS after intravenous thrombolysis, likely through regulating the activity of canonical Wnt signaling.

Indexed as

Administration, IntravenousAgedBrain IschemiaCerebral HemorrhageFemaleFibrinolytic AgentsGenetic VariationHumansIschemic StrokeMaleMiddle AgedPolymorphism, Single NucleotideReceptors, G-Protein-CoupledThrombolytic TherapyWnt ProteinsADGRA2 protein, humanFibrinolytic AgentsReceptors, G-Protein-CoupledWNT7A protein, humanWnt Proteinsblood-brain barrierintracerebral hemorrhageischemic strokesignaling pathwaysingle-nucleotide polymorphism

Identifiers

PMID32991049
PMCPMC7804912
OpenAlexW3090895554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.